Menulis Pandemi
Abstract
Dunia saat ini menghadapi situasi yang tidak pernah terjadi sebelumnya dalam sejarah manusia: pandemi Covid-19 (Gambar). Pengetahuan manusia mengenai penyakit Covid-19 secara pesat berkembang sejak laporan kasus awal dari Wuhan.1 Secara pesat, banyak laporan kasus, seri kasus, kohor dan belakangan studi mengenai Covid-19 dan tatalaksananya dilaporkan di berbagai jurnal. Beberapa jurnal esensial, seperti NEJM dan Lancet, bahkan menerbitkan isu khusus mengenai Covid-19. Pengetahuan tentang Covid-19 secara mayor boleh dikatakan berasal dari tiga klaster kohor epidemi; yaitu di China (terutama Wuhan), Italia, dan Amerika Serikat. Beberapa klaster lainnya, seperti dari Korea Selatan dan Jerman, melaporkan keberhasilan meredam perluasan epidemi.
Downloads
References
2. Nicin L, Abplanalp WT, Mellentin H, et al. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts, European Heart Journal, , ehaa311, https://doi.org/10.1093/eurheartj/ehaa311
3. FDA. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. FDA Drug Safety Communication 4-24-2020.
4. Mehra MR, Desai SS, Kuy S, et al. Cardiovascular disease, drug therapy, and mortali-ty in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
5. Meyer D. Privacy in a pandemic. Fortune, Asia Pacific edition 2020 May; 5:12-13.
6. European Society of Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Last update on 21 April 2020. Accessed at https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance?hit=home&urlorig=/vgn-ext-templating/
7. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Panduan Diagnosis dan Tatalaksana Penyakit Kardiovaskular pada Pandemi Covid-19. 9 Mei 2020. Akses: http://www.inaheart.org/upload/image/FINAL-Pan-duan_Diagnosis_dan_Tatalaksana_Penyakit_Kardiovaskular_pada_PANDEMI_COVID-19.pdf
PDF downloads: 2929
Copyright (c) 2020 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
